Literature DB >> 22336946

siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.

Valérie Pendaries, Géraldine Gasc, Matthias Titeux, Laure Tonasso, José Enrique Mejía, Alain Hovnanian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22336946     DOI： 10.1038/jid.2012.11

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  The cysteine-rich region of type VII collagen is a cystine knot with a new topology.

Authors:  Henrik Wegener; Hauke Paulsen; Karsten Seeger
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

2.  Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.

Authors:  Satoru Shinkuma; Zongyou Guo; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-03       Impact factor: 11.205

Review 3.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

Review 4.  Gene therapy and gene correction: targets, progress, and challenges for treating human diseases.

Authors:  Matthew R Cring; Val C Sheffield
Journal:  Gene Ther       Date:  2020-10-09       Impact factor: 5.250

Review 5.  Pathogenetic Therapy of Epidermolysis Bullosa: Current State and Prospects.

Authors:  I I Ryumina; K V Goryunov; D N Silachev; Yu A Shevtsova; V A Babenko; N M Marycheva; Yu Yu Kotalevskaya; V V Zubkov; G T Zubkov
Journal:  Bull Exp Biol Med       Date:  2021-05-29       Impact factor: 0.804

Review 6.  Advances in understanding and treating dystrophic epidermolysis bullosa.

Authors:  Michael J Vanden Oever; Jakub Tolar
Journal:  F1000Prime Rep       Date:  2014-05-06

Review 7.  RNA-based therapies for genodermatoses.

Authors:  Olivier Bornert; Patricia Peking; Jeroen Bremer; Ulrich Koller; Peter C van den Akker; Annemieke Aartsma-Rus; Anna M G Pasmooij; Eva M Murauer; Alexander Nyström
Journal:  Exp Dermatol       Date:  2017-01       Impact factor: 3.960

Review 8.  Investigational Treatments for Epidermolysis Bullosa.

Authors:  Ping-Chen Hou; Han-Tang Wang; Stasha Abhee; Wei-Ting Tu; John A McGrath; Chao-Kai Hsu
Journal:  Am J Clin Dermatol       Date:  2021-07-22       Impact factor: 7.403

9.  siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy.

Authors:  Véronique Bolduc; Yaqun Zou; Dayoung Ko; Carsten G Bönnemann
Journal:  Mol Ther Nucleic Acids       Date:  2014-02-11       Impact factor: 10.183

Review 10.  Basement membrane collagens and disease mechanisms.

Authors:  Anna Gatseva; Yuan Yan Sin; Gaia Brezzo; Tom Van Agtmael
Journal:  Essays Biochem       Date:  2019-09-13       Impact factor: 8.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.